Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Foxwell

Showing results (51-60 of 118) with videos related to

Pageof 12
Sort By:
The Journal of Emergency Medicine|January 1, 1990
Deep venous thrombosis of the upper extremity: diagnosis and treatmentE B Bolgiano, M M Foxwell, B J Browne, et al.
Journal of Palliative Medicine|July 8, 2024
Everyday Ethics or Deference to Expertise: Experiences of Pediatric Palliative Care Teams with Ethics ConsultancyAnessa M Foxwell, Connie M Ulrich, Jennifer K Walter, et al.
Journal of Palliative Medicine|May 25, 2017
Palliative Care Office Hours for Patients with Hematologic Malignancies: An Innovative Model for Symptom Management and EducationAnessa M Foxwell, Mary E Moyer, David J Casarett, et al.
Expert Reviews in Molecular Medicine|August 25, 2005
Molecular therapeutic targets in rheumatoid arthritisSandra M Sacre, Evangelos Andreakos, Peter Taylor, et al.
Annals of the Rheumatic Diseases|March 14, 2002
High efficiency gene transfer is an efficient way of defining therapeutic targets: a functional genomics approachB M Foxwell, S Yoshimura, J Bondeson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2006
Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvantE Andreakos, R O Williams, J Wales, et al.
Transplantation Proceedings|April 1, 1988
Biologic significance of cyclosporine metabolitesB Ryffel, B M Foxwell, M J Mihatsch, et al.
Toxicology|January 1, 1985
The use of anti-ricin antibodies to protect mice intoxicated with ricinB M Foxwell, S I Detre, T A Donovan, et al.
Biochemical Pharmacology|March 3, 1992
Covalent binding of cyclosporine inhibits irreversibly T-lymphocyte activationB Ryffel, G Woerly, V F Quesniaux, et al.
Annals of the Rheumatic Diseases|December 1, 1999
The rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards?M Feldmann, J Bondeson, F M Brennan, et al.
Pageof 12

Showing results (51-60 of 118) with videos related to

Sort By:
Pageof 12
The Journal of Emergency Medicine|January 1, 1990
Deep venous thrombosis of the upper extremity: diagnosis and treatmentE B Bolgiano, M M Foxwell, B J Browne, et al.
Journal of Palliative Medicine|July 8, 2024
Everyday Ethics or Deference to Expertise: Experiences of Pediatric Palliative Care Teams with Ethics ConsultancyAnessa M Foxwell, Connie M Ulrich, Jennifer K Walter, et al.
Journal of Palliative Medicine|May 25, 2017
Palliative Care Office Hours for Patients with Hematologic Malignancies: An Innovative Model for Symptom Management and EducationAnessa M Foxwell, Mary E Moyer, David J Casarett, et al.
Expert Reviews in Molecular Medicine|August 25, 2005
Molecular therapeutic targets in rheumatoid arthritisSandra M Sacre, Evangelos Andreakos, Peter Taylor, et al.
Annals of the Rheumatic Diseases|March 14, 2002
High efficiency gene transfer is an efficient way of defining therapeutic targets: a functional genomics approachB M Foxwell, S Yoshimura, J Bondeson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2006
Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvantE Andreakos, R O Williams, J Wales, et al.
Transplantation Proceedings|April 1, 1988
Biologic significance of cyclosporine metabolitesB Ryffel, B M Foxwell, M J Mihatsch, et al.
Toxicology|January 1, 1985
The use of anti-ricin antibodies to protect mice intoxicated with ricinB M Foxwell, S I Detre, T A Donovan, et al.
Biochemical Pharmacology|March 3, 1992
Covalent binding of cyclosporine inhibits irreversibly T-lymphocyte activationB Ryffel, G Woerly, V F Quesniaux, et al.
Annals of the Rheumatic Diseases|December 1, 1999
The rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards?M Feldmann, J Bondeson, F M Brennan, et al.
Pageof 12